BCL6 and familial pancreatic carcinoma: To determine if the PPARβ/δ/BCL-6 pathway is active in human pancreatic cancer cells, we used shRNA knock-down of PPARβ/δ and BCL-6 in conjunction with PPARβ/δ-specific activation by GW501516 to analyze the gene expression changes.